The company began producing breathing apparatuses for lung disease and asthma patients, according to daily Hurriyet.
Toksoz Holding board member Ahmet Toksoz was quoted by Hurriyet as saying that there are about 8 million patients suffering from chronic lung disease and asthma.
"There are potential patients both in Turkey and around the world. We have conducted six years of research and development work, with a total investment of 10 million euro," Toksoz added.
Sanovel is currently manufacturing over 150 human and veterinary products in a 40,000m² facility.